|
|||||
|
|
An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairment |
|
| Authors: | L. Peterson PhD T. Marbury MD J. Marier PhD FCP K. Laliberte Pharm D |
| Affiliation: | 1. United Therapeutics Corporation, , Research Triangle Park, NC, USA;2. Orlando Clinical Research Center, , Orlando, FL, USA;3. Pharsight – A Certara Company, , Montreal, Quebec, Canada |
| Abstract: | |
| Keywords: | clinical trials hepatic impairment pharmacokinetics pulmonary arterial hypertension treprostinil |